home / stock / oncy / oncy news


ONCY News and Press, Oncolytics Biotech Inc. From 01/20/22

Stock Information

Company Name: Oncolytics Biotech Inc.
Stock Symbol: ONCY
Market: NASDAQ
Website: oncolyticsbiotech.com

Menu

ONCY ONCY Quote ONCY Short ONCY News ONCY Articles ONCY Message Board
Get ONCY Alerts

News, Short Squeeze, Breakout and More Instantly...

ONCY - Gastrointestinal Cancer Treatment Trials Driven by Rising Incidences of Colorectal Cancer

Palm Beach, FL – January 20, 2022 – FinancialNewsMedia.com News Commentary – Despite significant progress in the treatment of gastric cancer, it is still among the leading causes of deaths due to cancer, across the world. The high mortality rates are pr...

ONCY - Oncolytics Biotech® Provides Enrollment Update on Multi-Indication Phase 1/2 Gastrointestinal Cancer Trial at the 2022 American Society of Clinical Oncology Gastrointestinal Cancers Symposium

Oncolytics Biotech® Provides Enrollment Update on Multi-Indication Phase 1/2 Gastrointestinal Cancer Trial at the 2022 American Society of Clinical Oncology Gastrointestinal Cancers Symposium Successfully enrolled first-line metastatic pancreatic and third-line metastatic c...

ONCY - 4 Penny Stocks To Buy For Under $4 Right Now

Ready to make 2022 your best year yet but confused on how to make money the way the stock market is today? Some are calling this the “Year of the Active Trader,” and for a good reason. With broad sector stocks up one day and down the next, a long-term approach to trading is mo...

ONCY - Breast Cancer Treatment Advancements Emerge After New Study Finds Global Deaths Increased in 2019

FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 14, 2022 – USA News Group –  Cancer cases are on the rise, according to a new study comparing the number of cancer diagnoses globally in 2010 and 2019. Among the ...

ONCY - Promising Developments in Breast Cancer Treatments Ahead in 2022

FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 12, 2022 – USA News Group –  So far in 2022, there have already been some impressive developments in the battle against breast cancer, which over the last decade has ...

ONCY - Oncolytics Biotech® Releases a Letter to Shareholders - 2021 Review and 2022 Outlook

Oncolytics Biotech® Releases a Letter to Shareholders - 2021 Review and 2022 Outlook Canada NewsWire SAN DIEGO, Calif. and CALGARY, AB , Jan. 11, 2022 /CNW/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) is providing a letter to sharehol...

ONCY - New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024

FN Media Group Presents USA News Group News Commentary Vancouver, BC –January 10, 2021 – USA News Group –  Nearly 10% of the estimated ~1.9 million new cancer cases in the USA will be diagnosed as leukemia, lymphoma and myeloma. According to...

ONCY - The Global Breast Cancer Treatment Market Expected To Reach $34.06 Billion By End Of 2026

Palm Beach, FL – December 21, 2021 – FinancialNewsMedia.com News Commentary – Breast cancer is cancer that develops in the breast tissue. Breast cancer signs include the formation of a lump in the breast and red patches on the skin. Obesity, lack of physical...

ONCY - Oncolytics Biotech® Promotes Thomas C. Heineman, M.D., Ph.D., to Chief Medical Officer

Oncolytics Biotech® Promotes Thomas C. Heineman, M.D., Ph.D., to Chief Medical Officer Canada NewsWire - Dr. Heineman has over two decades of experience successfully leading clinical development programs and previously served as Oncolytics' Global Head of Clinical...

ONCY - Ongoing R&D Leading to Discovery of More Efficient Therapies for Acute Myeloid Leukemia Therapeutics

Palm Beach, FL – December 15, 2021 – FinancialNewsMedia.com News Commentary – Acute Myeloid Leukemia (AML) is a type of blood cancer which usually affects white blood cells (WBCs), however, it can also start in other types of blood-forming cells. In AML, the...

Previous 10 Next 10